Over 90% of people with diabetes in the UK have type 2 diabetes, which doubles the risk of cardiovascular disease and reduces average life expectancy by seven years. These risks are partly driven by poor adherence:
The high level of non-compliance to diabetes medication is linked with:
Impact on pack sales increased steadily from month one of the patient support programme. By month 12, growth was 27% higher in our active pharmacies compared to inactive (control) pharmacies.
These results suggest that the patient support programme had a significant effect on patient adherence.